IA Intermittent Auscultation
CTG Cardiotocograph
EFM Electronic Fetal Monitoring
FHR Fetal Heart Rate
ARM Artificial Rupture of Membranes
PROM Prolonged Rupture of Membranes
We asked you in January to update to v4.7.2. After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.
To update to the latest release:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Welcome to the February 2025 update from the RDS team
A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:
The release will also incorporate a number of small fixes, including:
We will let you know when the date and time for the new release are confirmed.
There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.
The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.
Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.
At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .
We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.
Some important toolkits in development by the RDS team include:
The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.
To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)
To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form - also available in End-user and Provider sections of the RDS Learning and Support area. If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.
With kind regards
Right Decision Service team
Healthcare Improvement Scotland
The purpose of this policy is to give guidance to staff on the monitoring of the fetal heart in the antenatal and intrapartum period.
The most appropriate form of monitoring should be discussed with the woman to enable the woman to make informed choices regarding the method of monitoring the fetal heart. Due consideration must be given to maternal preference in addition to risk factors for both mother and baby. If a woman declines the recommended method of fetal monitoring the discussion and outcome should be documented in the clinical record.
Electronic Fetal Monitoring (EFM) with a cardiotocograph (CTG) should be the preferred and recommended method of monitoring of the fetal heart in labour for high-risk women. Intermittent Auscultation (IA) with a Doppler device or Pinard stethoscope should be the preferred and recommended method of monitoring of the fetal heart in labour for low risk women. This document is based on the recommendations of the National Institute for Health and Care Excellence guideline NG229 (published Dec 2022).
Qualified professionals should receive annual training on the interpretation and documentation relating to fetal monitoring.
IA Intermittent Auscultation
CTG Cardiotocograph
EFM Electronic Fetal Monitoring
FHR Fetal Heart Rate
ARM Artificial Rupture of Membranes
PROM Prolonged Rupture of Membranes
The on call Consultant Obstetrician holds overall responsibility of the high risk woman. The on call Obstetric Registrar is responsible for the clinical management of the high risk woman, escalating any concerns to the Consultant Obstetrician for an opinion or consultation. The Consultant Obstetrician is required to attend in person if requested by the Registrar or Senior Midwife.
The Senior Midwife in charge of labour ward is responsible for having an awareness or the management and progress of all women on labour ward, prioritising concerns identified by midwives and escalating appropriately to the on-call Registrar or Consultant Obstetrician.
The midwife is responsible for the care of the antenatal or labouring woman, escalating any concerns to the Senior Midwife or Registrar where appropriate.
A CTG can be reviewed remotely on Badgernet only on an NHS Borders computer but must not be shared on any social media platform or by mobile device. An image of the CTG, even if no identifiable information is present, must also never be shared on a social media platform or by mobile device.
Face to face review by consultant Obstetrician is indicated if
Complete a CTG label and attach at commencement of the CTG. Link CTG on Badgernet. When the CTG is discontinued complete a CTG review on Badgernet and have a CTG peer review completed by a colleague.
The appropriate method of fetal monitoring will be dictated by the maternal and fetal risk factors identified and a thorough assessment of the woman’s medical and obstetric history should be taken. The NICE guidelines (NICE Dec 2022) should be used to aid assessment of risk factors which necessitate continuous monitoring
The Intrapartum Risk Assessment on Badgernet indicates the appropriate method of fetal monitoring. Complete a CTG label upon commencement of the CTG.
1 Admission of Low Risk woman in Labour
For women categorised as ‘Low Risk’ with an uncomplicated pregnancy, current evidence does not support the use of an admission CTG or EFM and it is therefore not recommended (NICE 2022). However, risk assessment is a continual process, and women should be advised that the method of fetal heart rate monitoring may change throughout the course of labour.
During the initial assessment the fetal heart should be auscultated for a minimum of one minute immediately after a contraction and recorded as a single rate. The maternal pulse must be palpated to differentiate between maternal and fetal heart rate and recorded as part of a full set of maternal observations.
If a CTG had been commenced due to concerns from intermittent auscultation but there are no abnormal or non-reassuring features on the CTG, then the CTG can be discontinued after 30 minutes and return to intermittent auscultation.
In the 1st stage of labour the fetal heart should be auscultated after a contraction for at least a minute, every 15 minutes and documented in a labour assessment on Badgernet.
In the 2nd stage of labour the fetal heart should be auscultated after a contraction for at least a minute every 5 minutes and documented in a labour assessment on Badgernet or on paper records.
The maternal pulse should be palpated hourly throughout labour and documented in a labour assessment on Badgernet. If a fetal heart rate abnormality is detected, the maternal pulse should be palpated to differentiate the maternal and fetal heart rates.
2 Intrapartum indications to transfer from intermittent auscultation to continuous EFM
Base any decisions about moving to EFM from IA on clinical findings and discuss your recommendations with the woman and her birth partner.
Be aware intrapartum risk factors may increase the risk of fetal compromise, and that intrapartum risk factors that develop as labour progresses are particularly concerning. Staff should use the fetal monitoring risk assessment on Badgernet
Indications to offer transfer from IA to continuous fetal monitoring:
3 Antenatal indications for continuous fetal monitoring in labour
The NICE guidelines recommend continuous EFM for high risk women when in active labour;
Maternal Risk Factors
Fetal Risk Factors
Attach a CTG label at commencement of the CTG. Record the maternal pulse at commencement of EFM and hourly during labour.
Link the CTG to the record on BadgerNet.
Complete a CTG review hourly on BadgerNet and have a peer review completed by a colleague.
If there are concerning features on a CTG escalate to the labour ward co-ordinator without delay.
Mark significant intrapartum events on the CTG using the ‘CTG comments’ note on BadgerNet or by marking the CTG paper e.g;
If the quality of the CTG recording is unsatisfactory adjust the tocograph or transducer. If necessary apply a FSE with maternal consent to ensure accurate recording of the fetal heart. Please note that use of a FSE is contraindicated in the following circumstances;
4 Interpretation of the CTG
Make a documented systematic assessment of the condition of the woman and unborn baby (including cardiotocography [CTG] findings) every hour, or more frequently if there are concerns.
Do not make any decision about a woman's care in labour based on CTG findings alone.
Take into account the woman's preferences, any antenatal and intrapartum risk factors, the current wellbeing of the woman and unborn baby and the progress of labour. Ensure that the focus of care remains on the woman rather than the CTG trace.
Remain with the woman in order to continue providing one-to-one support.
Talk to the woman and her birth companion(s) about what is happening and take her preferences into account.
Principles for intrapartum CTG trace interpretation
When reviewing the CTG trace, categorise the 4 features of the CTG trace (contractions, baseline fetal heart rate; variability and decelerations) as WHITE, AMBER or RED – indicating levels of concern.
Categorise CTG traces as –
If there is a stable baseline fetal heart rate between 110 and 160 beats/minute and normal variability, continue usual care as the risk of fetal acidosis is low. If it is difficult to categorise or interpret a CTG trace, obtain a review by a senior midwife or a senior obstetrician.
Accelerations
The presence of fetal heart rate accelerations, even with reduced baseline variability, is generally a sign that the baby is healthy
White | Amber | Red | |
Contractions | < 5 | 5 or more in 10 mins Hypertonus | |
Baseline compare with earlier traces |
Stable 110-160bpm Lower rate expected with post term and higher rate in preterm pregnancies |
Increase of 20 or more 100-109bpm (continue usual care if this has been stable throughout labour and there is normal variability and no variable or late decels) Unable to determine |
< 100bpm >160bpm Increase of 20 beats in 2nd Stage |
Variability | 5 to 25bpm | <5 for 30-50mins >25 for up to 10 mins |
<5 for 50mins >25 for 10mins or more Sinusoidal |
Decelerations | No decels Early Decels Variable with no concerning features |
Repetitive variable with concerning features <30 mins Late Decels <30mins |
Repetitive variable * with concerning features >30mins Late decels >30mins Bradycardia |
Regard the following as concerning characteristics of variable decelerations:
Category | Definition | Management |
Normal |
No amber or red features (all 4 features are white) |
|
Suspicious |
1 amber feature |
If no other concerning features –
If there are additional intrapartum risk factors such as slow progress, sepsis or meconium;
|
Pathological |
1 abnormal feature OR 2 non-reassuring features |
|
Need for urgent intervention |
Acute bradycardia, or a single prolonged deceleration for 3 minutes or more |
|
* If there are any concerns about the baby's wellbeing, be aware of the possible underlying causes and start one or more of the following conservative measures based on an assessment of the most likely cause(s):
|
If the cardiotocograph trace is suspicious, offer digital fetal scalp stimulation. If this leads to an acceleration in fetal heart rate and a sustained improvement in the CTG trace, continue to monitor the fetal heart rate and clinical picture. Absence of an acceleration in response to fetal scalp stimulation is a worrying sign that fetal compromise may be present, and plan to expedite delivery should be considered. Fetal blood sampling is not currently recommended.
NICE guidelines recommend that paired cord blood samples are taken (arterial and venous). Cord blood gas analysis should be performed after every delivery and the results must be recorded on BadgerNet. The cord must be double clamped and analysed within 30 minutes. Document the length of time of deferred cord clamping (DCC) as this does affect the pH.
Antenatal CTGs should be filed on the standard mount sheet in the maternity case notes. Intrapartum CTGs should be stored in the CTG envelope in the maternity case notes. CTG traces are kept for a minimum of 25 years. The CTG forms part of the BadgerNet maternity record.